| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Burnout in the haematological workforce
|
The Lancet Haematology,
|
|
|
10 |
7 |
p. e477
|
article
|
| 2 |
Concerns on perioperative anaemia management in the FIT trial
|
Sato, Tomohiko
|
|
|
10 |
7 |
p. e485-e486
|
article
|
| 3 |
Concerns on perioperative anaemia management in the FIT trial
|
Petzer, Verena
|
|
|
10 |
7 |
p. e485
|
article
|
| 4 |
Correction to Lancet Haematol 2023; 10: e213–24
|
|
|
|
10 |
7 |
p. e490
|
article
|
| 5 |
Correction to Lancet Haematol 2023; 10: e433–44
|
|
|
|
10 |
7 |
p. e490
|
article
|
| 6 |
Correction to Lancet Haematol 2023; 10: e333–45
|
|
|
|
10 |
7 |
p. e490
|
article
|
| 7 |
Could improving mental health disorders help increase cancer survival?
|
Davies, Elizabeth A
|
|
|
10 |
7 |
p. e482-e484
|
article
|
| 8 |
CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?
|
Muus, Petra
|
|
|
10 |
7 |
p. e481-e482
|
article
|
| 9 |
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
|
Peterlin, Pierre
|
|
|
10 |
7 |
p. e521-e529
|
article
|
| 10 |
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
|
Hunger, Stephen P
|
|
|
10 |
7 |
p. e510-e520
|
article
|
| 11 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome
|
Shibusawa, Motoharu
|
|
|
10 |
7 |
p. e487-e488
|
article
|
| 12 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome
|
Halder, Rohan
|
|
|
10 |
7 |
p. e487
|
article
|
| 13 |
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome – Authors' reply
|
Grupp, Stephan A
|
|
|
10 |
7 |
p. e488-e489
|
article
|
| 14 |
Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians
|
Gurnari, Carmelo
|
|
|
10 |
7 |
p. e492-e494
|
article
|
| 15 |
Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma
|
O’Donnell, Jake S
|
|
|
10 |
7 |
p. e539-e548
|
article
|
| 16 |
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
|
Döhner, Hartmut
|
|
|
10 |
7 |
p. e495-e509
|
article
|
| 17 |
Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study
|
Kuczmarski, Thomas M
|
|
|
10 |
7 |
p. e530-e538
|
article
|
| 18 |
Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a common identity?
|
Semenzato, Gianpietro
|
|
|
10 |
7 |
p. e549-e556
|
article
|
| 19 |
More opportunities to advance paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia
|
Murphy, Lindsey
|
|
|
10 |
7 |
p. e479-e481
|
article
|
| 20 |
Oleksandr Lysytsia: the war in Ukraine has changed everything about our lives
|
Wilkinson, Emma
|
|
|
10 |
7 |
p. e491
|
article
|
| 21 |
The essential role of randomised controlled trials
|
Marini, Bernard L
|
|
|
10 |
7 |
p. e486-e487
|
article
|
| 22 |
Time to add gemtuzumab ozogamicin to intensive chemotherapy for NPM1-mutated acute myeloid leukaemia?
|
Othman, Jad
|
|
|
10 |
7 |
p. e478-e479
|
article
|
Journal description